Eli Lilly

Investments by market, targeted sectors and preferred funding rounds

Name - Eli Lilly
Web - none
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

biotech - 60%
healthtech - 40%

Number of investments: 5

Eli Lilly invested in Amphista Therapeutics during a round worth $53,000,000 - 3/17/2021
Eli Lilly invested in DTx Pharma during a round worth $100,000,000 - 3/5/2021
Eli Lilly invested in Evox Therapeutics during a round worth £69,200,000 - 2/18/2021
Eli Lilly invested in Seraxis during a round worth $40,000,000 - 2/9/2021
Eli Lilly invested in Immunocore during a round worth $130,000,000 - 3/18/2020